InvestorX
SEDAR® Issuer number:
00047392
Company name:
Thiogenesis Therapeutics, Corp. (formerly Rozdil Capital Corporation)
Document type:
Audited annual financial statements - English
Project number:
06120534
Filing date:
04-29-2024